Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer

Dhaval K. Shah, Jean Veith, Ralph J. Bernacki, Joseph P. Balthasar
October 1, 2011
Learn More
LinkedIn